section name header

Basics ⬇

DESCRIPTION navigator

ETIOLOGY navigator

Proposed causative agents:


[Outline]

Diagnosis ⬆ ⬇

SIGNS AND SYMPTOMS navigator

History

Physical Exam

Pediatric Considerations

ESSENTIAL WORKUP navigator

DIAGNOSIS TESTS & INTERPRETATION navigator

Lab

Imaging

Diagnostic Procedures/Surgery

DIFFERENTIAL DIAGNOSIS navigator


[Outline]

Treatment ⬆ ⬇

PRE-HOSPITAL navigator

Pain control as appropriate

INITIAL STABILIZATION/THERAPY navigator

ED TREATMENT/PROCEDURES navigator

MEDICATION navigator

First Line

Second Line

Topiramate has been suggested as a 2nd-line agent but is not FDA approved for this use


[Outline]

Follow-Up ⬆ ⬇

DISPOSITION navigator

Admission Criteria

Acute or impending visual loss

Discharge Criteria

Issues for Referral

Timely referral and return precautions:

FOLLOW-UP RECOMMENDATIONS navigator

Follow-up is recommended with neurology and ophthalmology


[Outline]

Pearls and Pitfalls ⬆ ⬇

Codes ⬆ ⬇

ICD9 navigator

348.2 Benign intracranial hypertension

ICD10 navigator

G93.2 Benign intracranial hypertension


[Outline]

Reference(s) ⬆ ⬇

See Also (Topic, Algorithm, Electronic Media Element)

Author(s) ⬆

Ian Reilly